BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2418979)

  • 21. Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients.
    Waller BF; McManus BM; Gorfinkel HJ; Kishel JC; Schmidt EC; Kent KM; Roberts WC
    Am J Cardiol; 1983 Jan; 51(1):81-4. PubMed ID: 6217740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous transluminal coronary angioplasty.
    Levin DC; Boxt LM; Meyerovitz MF
    Radiol Clin North Am; 1985 Dec; 23(4):597-611. PubMed ID: 2933762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coronary artery spasm with anaphylactoid shock due to low-molecular dextran].
    Leisch F
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1027-9. PubMed ID: 2472259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical procedures after percutaneous transluminal coronary angioplasty.
    Alford WC; Stoney WS; Page HL; Burrus GR; Glassford DM; Petracek MR; Thomas CS
    South Med J; 1982 Dec; 75(12):1556-8. PubMed ID: 6216602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branch retinal artery occlusion secondary to percutaneous transluminal coronary angioplasty.
    Bucci FA; Dimitsopulos TM; Krohel GB
    Br J Ophthalmol; 1989 Apr; 73(4):309-10. PubMed ID: 2523726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary arterial aneurysm formation after balloon angioplasty.
    Hill JA; Margolis JR; Feldman RL; Conti CR; Pepine CJ
    Am J Cardiol; 1983 Aug; 52(3):261-4. PubMed ID: 6223521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left main coronary artery dissection during percutaneous transluminal coronary angioplasty.
    Slack JD; Pinkerton CA; VanTassel JW; Orr CM
    Cathet Cardiovasc Diagn; 1986; 12(4):255-60. PubMed ID: 2944595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse reactions to dextran in Sweden 1970-1979.
    Ljungström KG; Renck H; Strandberg K; Hedin H; Richter W; Widerlöv E
    Acta Chir Scand; 1983; 149(3):253-62. PubMed ID: 6193664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Percutaneous dilatation of coronary artery stenoses (percutaneos transluminal coronary angioplasty, PTCA) (author's transl)].
    Sesto M; Pustisek S; Ivancić R; Custović F
    Lijec Vjesn; 1981 Oct; 103(10):447-50. PubMed ID: 6210814
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dextran-induced anaphylactoid reactions in two patients with gastrointestinal cancer].
    Miyamoto Y; Tashiro C
    Masui; 1996 Apr; 45(4):500-3. PubMed ID: 8725611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Death from coronary air embolism during percutaneous transluminal coronary angioplasty.
    Bentivoglio LG; Leo LR
    Cathet Cardiovasc Diagn; 1985; 11(6):585-90. PubMed ID: 2936458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute occlusion developing during or immediately after percutaneous transluminal coronary angioplasty: nonsurgical treatment.
    Meyerovitz MF; Friedman PL; Ganz P; Selwyn AP; Levin DC
    Radiology; 1988 Nov; 169(2):491-4. PubMed ID: 2971984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery dissection after transluminal angioplasty. Possible deleterious effects of treatment with intracoronary streptokinase.
    Steffenino G; Meier B; Velebit V; Finci L
    G Ital Cardiol; 1986 May; 16(5):436-8. PubMed ID: 2942436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Japanese survey on first attempts of percutaneous transluminal coronary angioplasty.
    Sekiguchi M; Ban T; Chino M; Endo M; Fujimoto K; Higa K; Hori M; Kanbara H; Kodama K; Nakajima M
    Jpn Circ J; 1985 Oct; 49(10):1113-6. PubMed ID: 2935647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Our experience with percutaneous transluminal coronary angioplasty--two years follow-up study.
    Kaul U; Sharma SN; Manchanda SL; Rajani M; Sharma S; Bahl VK; Bhartia ML; Venugopal P
    Indian Heart J; 1989; 41(3):142-9. PubMed ID: 2528502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy.
    Kohchi K; Takebayashi S; Block PC; Hiroki T; Nobuyoshi M
    J Am Coll Cardiol; 1987 Sep; 10(3):592-9. PubMed ID: 2957413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary arterial rupture during coronary angioplasty.
    Saffitz JE; Rose TE; Oaks JB; Roberts WC
    Am J Cardiol; 1983 Mar; 51(5):902-4. PubMed ID: 6219571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous transluminal angioplasty.
    Ann Intern Med; 1983 Dec; 99(6):864-9. PubMed ID: 6228175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe and fatal reactions to rheomacrodex.
    Vandamme JP
    Acta Chir Belg; 1975 Sep; 74(5):531-5. PubMed ID: 1220497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.